A study of PEGASYS [peginterferon alfa-2a] in patients pretreated with lamivudine or interferon who have HBeAg-positive hepatitis B infection.
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2010
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Roche
- 15 Feb 2008 Status changed from in progress to completed; according to Roche.
- 10 Jan 2008 Status changed from recruiting to in progress.
- 20 Jun 2006 New trial record.